{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03337022: Phase 1 Interventional Completed Psoriasis
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02947152: Phase 1 Interventional Terminated Epithelial Ovarian Cancer
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
USAN:ONTERODRIMER [USAN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02473731: Phase 1 Interventional Completed Squamous Cell Carcinoma of the Head and Neck
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04021043: Phase 1/Phase 2 Interventional Active, not recruiting Advanced Malignant Solid Neoplasm
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03449030: Phase 1 Interventional Terminated Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03582033: Phase 1 Interventional Terminated Multiple Myeloma
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03035279: Phase 1 Interventional Terminated Colorectal Cancer
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03705169: Phase 1 Interventional Terminated HIV-1-infection
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04701164: Phase 3 Interventional Recruiting Guillain-Barre Syndrome
(2020)
Source URL:
Class:
CONCEPT